AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
342: FDA cuts, zombie biotechs, and too much weight loss?
The Readout Loud
Redundancies and Challenges in Biotech: The Case of Off-the-Shelf Cell Therapies
This chapter delves into the challenges faced by biotech companies in the realm of off-the-shelf cell therapies, such as CAR T treatments. The discussion highlights inefficiencies due to overlapping efforts among firms and recent shifts in focus from oncology to autoimmune therapies.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode